CA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVECOVER ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


CA Cancer J Clin 2004; 54:8
doi: 10.3322/canjclin.54.1.8
© 2004 American Cancer Society
This Article
Right arrow Full Text Freely available
Right arrow Full Text (PDF) Freely available
Right arrow Freely available CME: Take the course for this article:
Cancer Statistics, 2004
Right arrow Submit a letter to the editor
Right arrow View responses
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jemal, A.
Right arrow Articles by Thun, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jemal, A.
Right arrow Articles by Thun, M. J.

Cancer Statistics, 2004

Ahmedin Jemal, DVM, PhD, Ram C. Tiwari, PhD, Taylor Murray, Asma Ghafoor, MPH, Alicia Samuels, MPH, Elizabeth Ward, PhD, Eric J. Feuer, PhD and Michael J. Thun, MD, MS


Dr. Jemal is Program Director, Cancer Occurrence, Department of Epidemiology and Surveillance Research, American Cancer Society, Atlanta, GA.
Dr. Tiwari is Mathematical Statistician, Statistical Research and Applications Branch, Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, MD.
Mr. Murray is Manager, Surveillance Data Systems, Department of Epidemiology and Surveillance Research, American Cancer Society, Atlanta, GA.
Ms. Ghafoor is Epidemiologist, Department of Epidemiology and Surveillance Research, American Cancer Society, Atlanta, GA.
Ms. Samuels is Manager, Surveillance Information Services, Department of Epidemiology and Surveillance Research, American Cancer Society, Atlanta, GA.
Dr. Ward is Director, Surveillance Research, Department of Epidemiology and Surveillance Research, American Cancer Society, Atlanta, GA.
Dr. Feuer is Branch Chief, Statistical Research and Applications Branch, Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, MD.
Dr. Thun is Vice-President, Department of Epidemiology and Surveillance Research, American Cancer Society, Atlanta, GA.

Each year, the American Cancer Society estimates the number of new cancer cases and deaths expected in the United States in the current year and compiles the most recent data on cancer incidence, mortality, and survival rates based on incidence data from the National Cancer Institute and mortality data from the National Center for Health Statistics. Incidence and mortality rates are age standardized to the 2000 US standard million population. A total of 1,368,030 new cancer cases and 563,700 deaths are expected in the United States in 2004. Incidence rates stabilized among men from 1995 through 2000 but continued to increase among females by 0.4% per year from 1987 through 2000. Mortality rates have decreased by 1.5% per year since 1992 among men, but have stabilized from 1998 through 2000 among women. Cancer death rates continued to decrease from the three major cancer sites in men (lung and bronchus, colon and rectum, and prostate) and from female breast and colorectal cancers in women. In analyses by race and ethnicity, African-American men and women have 40% and 20% higher death rates from all cancers combined compared with White men and women, respectively. Cancer incidence and mortality rates are lower in other racial and ethnic groups than in Whites and African Americans for all sites combined and for the four major cancer sites. However, these groups generally have higher rates for stomach, liver, and cervical cancers than do Whites. Furthermore, minority populations are more likely to be diagnosed with advanced stage disease than are Whites. Progress in reducing the burden from cancer can be accelerated by applying existing cancer control knowledge into practice among all segments of the population.




This article has been cited by other articles:


Home page
Jpn J Clin OncolHome page
S. Shirotake, E. Kikuchi, K. Matsumoto, S. Yazawa, T. Kosaka, A. Miyajima, K. Nakagawa, and M. Oya
Role of Pelvic Lymph Node Dissection in Lymph Node-Negative Patients with Invasive Bladder Cancer
Jpn. J. Clin. Oncol., March 1, 2010; 40(3): 247 - 251.
[Abstract] [Full Text] [PDF]


Home page
Evid Based Complement Alternat MedHome page
R.-L. Tsai, B.-Y. Ho, and T.-M. Pan
Red Mold Rice Mitigates Oral Carcinogenesis in 7,12-Dimethyl-1,2-Benz[a]anthracene-induced Oral Carcinogenesis in Hamster
Evid. Based Complement. Altern. Med., December 17, 2009; (2009) nep215v1.
[Abstract] [Full Text] [PDF]


Home page
DMMHome page
J. A. Fowler, G. R. Mundy, S. T. Lwin, C. C. Lynch, and C. M. Edwards
A murine model of myeloma that allows genetic manipulation of the host microenvironment
Dis. Model. Mech., November 1, 2009; 2(11-12): 604 - 611.
[Abstract] [Full Text] [PDF]


Home page
Anticancer ResHome page
A. GOERGENS, M. FRERICKS, and C. ESSER
The Arylhydrocarbon Receptor Is Only Marginally Involved in the Antileukemic Effects of its Ligand Curcumin
Anticancer Res, November 1, 2009; 29(11): 4657 - 4664.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. P. S. Crawford, H. Yang, K. R. Mattaini, and K. W. Hunter
The Metastasis Efficiency Modifier Ribosomal RNA Processing 1 Homolog B (RRP1B) Is a Chromatin-associated Factor
J. Biol. Chem., October 16, 2009; 284(42): 28660 - 28673.
[Abstract] [Full Text] [PDF]


Home page
Anticancer ResHome page
L. SKAGIAS, E. POLITI, A. KARAMERIS, D. SAMBAZIOTIS, A. ARCHONDAKIS, A. NTINIS, I. MOREAS, O. VASOU, H. KOUTSELINI, and E. PATSOURIS
Survivin Expression as a Strong Indicator of Recurrence in Urothelial Bladder Cancer. Predictive Value of Nuclear versus Cytoplasmic Staining
Anticancer Res, October 1, 2009; 29(10): 4163 - 4167.
[Abstract] [Full Text] [PDF]


Home page
Anticancer ResHome page
M. G. FABRINI, A. GADDUCCI, F. PERRONE, S. COSIO, C. LALISCIA, F. PASQUALETTI, S. GRESPI, and L. CIONINI
Clinical Outcome of Tailored Adjuvant Postoperative Chemoradiotherapy in IB FIGO Stage Cervical Cancer
Anticancer Res, October 1, 2009; 29(10): 4205 - 4210.
[Abstract] [Full Text] [PDF]


Home page
Anticancer ResHome page
T. TAHARA, T. SHIBATA, M. NAKAMURA, H. YAMASHITA, D. YOSHIOKA, I. HIRATA, and T. ARISAWA
RANTES Promoter Genotype and Gastric Cancer Risk in a Japanese Population
Anticancer Res, October 1, 2009; 29(10): 4265 - 4269.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
G. B. W. Wertheim, T. W. Yang, T.-c. Pan, A. Ramne, Z. Liu, H. P. Gardner, K. D. Dugan, P. Kristel, B. Kreike, M. J. van de Vijver, et al.
The Snf1-related kinase, Hunk, is essential for mammary tumor metastasis
PNAS, September 15, 2009; 106(37): 15855 - 15860.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
R. W. Jang, A. Le Maitre, K. Ding, T. Winton, A. Bezjak, L. Seymour, F. A. Shepherd, and N. B. Leighl
Quality-Adjusted Time Without Symptoms or Toxicity Analysis of Adjuvant Chemotherapy in Non-Small-Cell Lung Cancer: An Analysis of the National Cancer Institute of Canada Clinical Trials Group JBR.10 Trial
J. Clin. Oncol., September 10, 2009; 27(26): 4268 - 4273.
[Abstract] [Full Text] [PDF]


Home page
Anticancer ResHome page
P. SERTZNIG, T. DUNLOP, M. SEIFERT, W. TILGEN, and J. REICHRATH
Cross-talk between Vitamin D Receptor (VDR)- and Peroxisome Proliferator-activated Receptor (PPAR)-signaling in Melanoma Cells
Anticancer Res, September 1, 2009; 29(9): 3647 - 3658.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
W. Dale
"Staging the Aging" When Considering Androgen Deprivation Therapy for Older Men With Prostate Cancer
J. Clin. Oncol., July 20, 2009; 27(21): 3420 - 3422.
[Full Text] [PDF]


Home page
BloodHome page
A. K. Azab, F. Azab, S. Blotta, C. M. Pitsillides, B. Thompson, J. M. Runnels, A. M. Roccaro, H. T. Ngo, M. R. Melhem, A. Sacco, et al.
RhoA and Rac1 GTPases play major and differential roles in stromal cell-derived factor-1-induced cell adhesion and chemotaxis in multiple myeloma
Blood, July 16, 2009; 114(3): 619 - 629.
[Abstract] [Full Text] [PDF]


Home page
J. Histochem. Cytochem.Home page
F. A. Miranda, M. K. Hassumi, M. C.M. Guimaraes, R. T. Simoes, T. G.A. Silva, R. C.P. Lira, A. M. Rocha, C. T. Mendes Jr., E. A. Donadi, C. P. Soares, et al.
Galectin-3 Overexpression in Invasive Laryngeal Carcinoma, Assessed by Computer-assisted Analysis
J. Histochem. Cytochem., July 1, 2009; 57(7): 665 - 673.
[Abstract] [Full Text] [PDF]


Home page
Ann OncolHome page
A. Buhmeida, R. Bendardaf, M. Hilska, J. Laine, Y. Collan, M. Laato, K. Syrjanen, and S. Pyrhonen
PLA2 (group IIA phospholipase A2) as a prognostic determinant in stage II colorectal carcinoma
Ann. Onc., July 1, 2009; 20(7): 1230 - 1235.
[Abstract] [Full Text] [PDF]


Home page
Anticancer ResHome page
D. PROSCHEK, A. KURTH, P. PROSCHEK, T. J. VOGL, and M. G. MACK
Prospective Pilot-study of Combined Bipolar Radiofrequency Ablation and Application of Bone Cement in Bone Metastases
Anticancer Res, July 1, 2009; 29(7): 2787 - 2792.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
A. S. Andrew, R. A. Mason, V. Memoli, and E. J. Duell
Arsenic Activates EGFR Pathway Signaling in the Lung
Toxicol. Sci., June 1, 2009; 109(2): 350 - 357.
[Abstract] [Full Text] [PDF]


Home page
Anticancer ResHome page
P. SOORIAKUMARAN, H. M. COLEY, S. B. FOX, P. MACANAS-PIRARD, D. P. LOVELL, A. HENDERSON, C. G. EDEN, P. D. MILLER, S. E.M. LANGLEY, and R. W. LAING
A Randomized Controlled Trial Investigating the Effects of Celecoxib in Patients with Localized Prostate Cancer
Anticancer Res, May 1, 2009; 29(5): 1483 - 1488.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
W. J. Lubbe, D. S. Zuzga, Z. Zhou, W. Fu, J. Pelta-Heller, R. J. Muschel, S. A. Waldman, and G. M. Pitari
Guanylyl Cyclase C Prevents Colon Cancer Metastasis by Regulating Tumor Epithelial Cell Matrix Metalloproteinase-9
Cancer Res., April 15, 2009; 69(8): 3529 - 3536.
[Abstract] [Full Text] [PDF]


Home page
Health Educ ResHome page
S. L. McFall, J. Ureda, T. L. Byrd, A. Valdes, P. Morales, D. B. Scott, D. Williams, J. Calderon-Mora, M. E. Casillas, and E. C. Y. Chan
What is needed for informed decisions about prostate cancer screening: perspectives of African-American and Hispanic men
Health Educ. Res., April 1, 2009; 24(2): 280 - 291.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
Z. Saidak, R. Mentaverri, and E. M. Brown
The Role of the Calcium-Sensing Receptor in the Development and Progression of Cancer
Endocr. Rev., April 1, 2009; 30(2): 178 - 195.
[Abstract] [Full Text] [PDF]


Home page
Ann OncolHome page
M. Ychou, J.-L. Raoul, J.-Y. Douillard, S. Gourgou-Bourgade, R. Bugat, L. Mineur, F. Viret, Y. Becouarn, O. Bouche, E. Gamelin, et al.
A phase III randomised trial of LV5FU2 + irinotecan versus LV5FU2 alone in adjuvant high-risk colon cancer (FNCLCC Accord02/FFCD9802)
Ann. Onc., April 1, 2009; 20(4): 674 - 680.
[Abstract] [Full Text] [PDF]


Home page
Anticancer ResHome page
S. H. KIM, K. ZUKOWSKI, and R. F. NOVAK
Rapamycin Effects on mTOR Signaling in Benign, Premalignant and Malignant Human Breast Epithelial Cells
Anticancer Res, April 1, 2009; 29(4): 1143 - 1150.
[Abstract] [Full Text] [PDF]


Home page
Cancer Genomics ProteomicsHome page
P. SOORIAKUMARAN, P. MACANAS-PIRARD, G. BUCCA, A. HENDERSON, S.E.M. LANGLEY, R.W. LAING, C.P. SMITH, E.E. LAING, and H.M. COLEY
A Gene Expression Profiling Approach Assessing Celecoxib in a Randomized Controlled Trial in Prostate Cancer
Cancer Genomics Proteomics, March 1, 2009; 6(2): 93 - 99.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. Kwon, S. Stephan, A. Mukhopadhyay, M. H. Muders, S. K. Dutta, J. S. Lau, and D. Mukhopadhyay
Insulin Receptor Substrate-2 Mediated Insulin-like Growth Factor-I Receptor Overexpression in Pancreatic Adenocarcinoma through Protein Kinase C{delta}
Cancer Res., February 15, 2009; 69(4): 1350 - 1357.
[Abstract] [Full Text] [PDF]


Home page
Jpn J Clin OncolHome page
W.-C. Hsieh, Y.-W. Cheng, C.-J. Lin, M.-C. Chou, C.-Y. Chen, and H. Lee
Prognostic Significance of X-ray Cross-complementing Group 1 T-77C Polymorphism in Resected Non-small Cell Lung Cancer
Jpn. J. Clin. Oncol., February 1, 2009; 39(2): 81 - 85.
[Abstract] [Full Text] [PDF]


Home page
J Am Acad Orthop SurgHome page
N. F. Gilbert, C. P. Cannon, P. P. Lin, and V. O. Lewis
Soft-tissue Sarcoma
J. Am. Acad. Ortho. Surg., January 1, 2009; 17(1): 40 - 47.
[Abstract] [Full Text] [PDF]


Home page
Anticancer ResHome page
A. BUHMEIDA, M. HILSKA, A. ELZAGHEID, M. LAATO, Y. COLLAN, K. SYRJANEN, and S. PYRHONEN
DNA Image Cytometry Predicts Disease Outcome in Stage II Colorectal Carcinoma
Anticancer Res, January 1, 2009; 29(1): 99 - 106.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
D. L. Blum, T. Koyama, A. E. M'Koma, J. M. Iturregui, M. Martinez-Ferrer, C. Uwamariya, J. A. Smith Jr., P. E. Clark, and N. A. Bhowmick
Chemokine Markers Predict Biochemical Recurrence of Prostate Cancer following Prostatectomy
Clin. Cancer Res., December 1, 2008; 14(23): 7790 - 7797.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
H. R. Qin, H.-J. Kim, J.-Y. Kim, E. M. Hurt, G. J. Klarmann, B. T. Kawasaki, M. A. Duhagon Serrat, and W. L. Farrar
Activation of Signal Transducer and Activator of Transcription 3 through a Phosphomimetic Serine 727 Promotes Prostate Tumorigenesis Independent of Tyrosine 705 Phosphorylation
Cancer Res., October 1, 2008; 68(19): 7736 - 7741.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
J. M. Bailey, B. J. Swanson, T. Hamada, J. P. Eggers, P. K. Singh, T. Caffery, M. M. Ouellette, and M. A. Hollingsworth
Sonic Hedgehog Promotes Desmoplasia in Pancreatic Cancer
Clin. Cancer Res., October 1, 2008; 14(19): 5995 - 6004.
[Abstract] [Full Text] [PDF]


Home page
Ann OncolHome page
B. R. Knab, J. K. Salama, A. Solanki, K. M. Stenson, E. E. Cohen, M. E. Witt, D. J. Haraf, and E. E. Vokes
Functional organ preservation with definitive chemoradiotherapy for T4 laryngeal squamous cell carcinoma
Ann. Onc., September 1, 2008; 19(9): 1650 - 1654.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
M. Eiblmaier, L. A. Meyer, M. A. Watson, P. M. Fracasso, L. J. Pike, and C. J. Anderson
Correlating EGFR Expression with Receptor-Binding Properties and Internalization of 64Cu-DOTA-Cetuximab in 5 Cervical Cancer Cell Lines
J. Nucl. Med., September 1, 2008; 49(9): 1472 - 1479.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
B. A Gilchrest
Sun exposure and vitamin D sufficiency
Am. J. Clinical Nutrition, August 1, 2008; 88(2): 570S - 577S.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
G. M. Pitari, J. E. Lin, F. J. Shah, W. J. Lubbe, D. S. Zuzga, P. Li, S. Schulz, and S. A. Waldman
Enterotoxin preconditioning restores calcium-sensing receptor-mediated cytostasis in colon cancer cells
Carcinogenesis, August 1, 2008; 29(8): 1601 - 1607.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
V. Masciullo, E. Berardengo, A. Boglione, A. Sgambato, A. Bernardi, M. Forni, A. Linari, L. Cito, G. Scambia, A. Comandone, et al.
The Retinoblastoma Family Member pRb2/p130 Is an Independent Predictor of Survival in Human Soft Tissue Sarcomas
Clin. Cancer Res., August 1, 2008; 14(15): 4775 - 4779.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
G. Lu, H. Xiao, H. You, Y. Lin, H. Jin, B. Snagaski, and C. S. Yang
Synergistic Inhibition of Lung Tumorigenesis by a Combination of Green Tea Polyphenols and Atorvastatin
Clin. Cancer Res., August 1, 2008; 14(15): 4981 - 4988.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
R. M. Summers, L. R. Handwerker, P. J. Pickhardt, R. L. Van Uitert, K. K. Deshpande, S. Yeshwant, J. Yao, and M. Franaszek
Performance of a Previously Validated CT Colonography Computer-Aided Detection System in a New Patient Population
Am. J. Roentgenol., July 1, 2008; 191(1): 168 - 174.
[Abstract] [Full Text] [PDF]


Home page
Ann OncolHome page
A. Psyrri, P. Kountourakis, A. Scorilas, S. Markakis, R. Camp, D. Kowalski, E. P. Diamandis, and M. A. Dimopoulos
Human tissue kallikrein 7, a novel biomarker for advanced ovarian carcinoma using a novel in situ quantitative method of protein expression
Ann. Onc., July 1, 2008; 19(7): 1271 - 1277.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
V. R. Placencio, A.-R. Sharif-Afshar, X. Li, H. Huang, C. Uwamariya, E. G. Neilson, M. M. Shen, R. J. Matusik, S. W. Hayward, and N. A. Bhowmick
Stromal Transforming Growth Factor-{beta} Signaling Mediates Prostatic Response to Androgen Ablation by Paracrine Wnt Activity
Cancer Res., June 15, 2008; 68(12): 4709 - 4718.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. ProteomicsHome page
R. Ralhan, L. V. DeSouza, A. Matta, S. Chandra Tripathi, S. Ghanny, S. Datta Gupta, S. Bahadur, and K. W. M. Siu
Discovery and Verification of Head-and-neck Cancer Biomarkers by Differential Protein Expression Analysis Using iTRAQ Labeling, Multidimensional Liquid Chromatography, and Tandem Mass Spectrometry
Mol. Cell. Proteomics, June 1, 2008; 7(6): 1162 - 1173.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
K. Kitajima, K. Murakami, E. Yamasaki, I. Fukasawa, N. Inaba, Y. Kaji, and K. Sugimura
Accuracy of 18F-FDG PET/CT in Detecting Pelvic and Paraaortic Lymph Node Metastasis in Patients with Endometrial Cancer
Am. J. Roentgenol., June 1, 2008; 190(6): 1652 - 1658.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Vicent, D. Luis-Ravelo, I. Anton, I. Garcia-Tunon, F. Borras-Cuesta, J. Dotor, J. De Las Rivas, and F. Lecanda
A Novel Lung Cancer Signature Mediates Metastatic Bone Colonization by a Dual Mechanism
Cancer Res., April 1, 2008; 68(7): 2275 - 2285.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
L. M. Cotton, M. K. O'Bryan, and B. T. Hinton
Cellular Signaling by Fibroblast Growth Factors (FGFs) and Their Receptors (FGFRs) in Male Reproduction
Endocr. Rev., April 1, 2008; 29(2): 193 - 216.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
Y. Takei, Y. Saga, H. Mizukami, T. Takayama, M. Ohwada, K. Ozawa, and M. Suzuki
Overexpression of PTEN in ovarian cancer cells suppresses i.p. dissemination and extends survival in mice
Mol. Cancer Ther., March 1, 2008; 7(3): 704 - 711.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
J. W. Fletcher, B. Djulbegovic, H. P. Soares, B. A. Siegel, V. J. Lowe, G. H. Lyman, R. E. Coleman, R. Wahl, J. C. Paschold, N. Avril, et al.
Recommendations on the Use of 18F-FDG PET in Oncology
J. Nucl. Med., March 1, 2008; 49(3): 480 - 508.
[Abstract] [Full Text] [PDF]


Home page
Arch SurgHome page
R. Steinert, M. Hantschick, M. Vieth, I. Gastinger, F. Kuhnel, H. Lippert, and M. A. Reymond
Influence of Subclinical Tumor Spreading on Survival After Curative Surgery for Colorectal Cancer
Arch Surg, February 1, 2008; 143(2): 122 - 128.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
T. J. Dubinsky, C. Cuevas, M. K. Dighe, O. Kolokythas, and J. H. Hwang
High-Intensity Focused Ultrasound: Current Potential and Oncologic Applications
Am. J. Roentgenol., January 1, 2008; 190(1): 191 - 199.
[Abstract] [Full Text] [PDF]


Home page
J Am Osteopath AssocHome page
G. H. Pharo
Optimizing Living With Cancer Pain
J Am Osteopath Assoc, December 1, 2007; 107(suppl_7): ES1 - ES2.
[Full Text] [PDF]


Home page
Ann OncolHome page
D. -W. Kim, S. -Y. Kim, H. -K. Kim, S. -W. Kim, S. W. Shin, J. S. Kim, K. Park, M. Y. Lee, and D. S. Heo
Multicenter phase II trial of Genexol-PM, a novel Cremophor-free, polymeric micelle formulation of paclitaxel, with cisplatin in patients with advanced non-small-cell lung cancer
Ann. Onc., December 1, 2007; 18(12): 2009 - 2014.
[Abstract] [Full Text] [PDF]


Home page
Ann OncolHome page
D. J. Gallagher, M. Capanu, G. Raggio, and N. Kemeny
Hepatic arterial infusion plus systemic irinotecan in patients with unresectable hepatic metastases from colorectal cancer previously treated with systemic oxaliplatin: a retrospective analysis
Ann. Onc., December 1, 2007; 18(12): 1995 - 1999.
[Abstract] [Full Text] [PDF]


Home page
J Am Osteopath AssocHome page
G. H. Pharo and L. Zhou
Controlling Cancer Pain With Pharmacotherapy
J Am Osteopath Assoc, December 1, 2007; 107(suppl_7): ES22 - ES32.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
P. Li, J. E. Lin, I. Chervoneva, S. Schulz, S. A. Waldman, and G. M. Pitari
Homeostatic Control of the Crypt-Villus Axis by the Bacterial Enterotoxin Receptor Guanylyl Cyclase C Restricts the Proliferating Compartment in Intestine
Am. J. Pathol., December 1, 2007; 171(6): 1847 - 1858.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
A.-M. Boller and H. Nelson
Colon and Rectal Cancer: Laparoscopic or Open?
Clin. Cancer Res., November 15, 2007; 13(22): 6894s - 6896s.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
J.-L. Monin, M. Monchi, M. E.W. Kirsch, H. Petit-Eisenmann, S. Baleynaud, C. Chauvel, D. Metz, C. Adams, J.-P. Quere, P. Gueret, et al.
Low-gradient aortic stenosis: impact of prosthesis-patient mismatch on survival
Eur. Heart J., November 1, 2007; 28(21): 2620 - 2626.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Y. Liu, H. G. Vikis, Y. Yi, M. Futamura, Y. Wang, and M. You
Degradation of Lung Adenoma Susceptibility 1, a Major Candidate Mouse Lung Tumor Modifier, Is Required for Cell Cycle Progression
Cancer Res., November 1, 2007; 67(21): 10207 - 10213.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. ProteomicsHome page
V. Kulasingam and E. P. Diamandis
Proteomics Analysis of Conditioned Media from Three Breast Cancer Cell Lines: A Mine for Biomarkers and Therapeutic Targets
Mol. Cell. Proteomics, November 1, 2007; 6(11): 1997 - 2011.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
S. S. N. Kolar, R. Barhoumi, E. S. Callaway, Y.-Y. Fan, N. Wang, J. R. Lupton, and R. S. Chapkin
Synergy between docosahexaenoic acid and butyrate elicits p53-independent apoptosis via mitochondrial Ca2+ accumulation in colonocytes
Am J Physiol Gastrointest Liver Physiol, November 1, 2007; 293(5): G935 - G943.
[Abstract] [Full Text] [PDF]


Home page
Ann OncolHome page
S. Oudard, E. Banu, F. Scotte, A. Banu, J. Medioni, P. Beuzeboc, F. Joly, J.-M. Ferrero, F. Goldwasser, and J.-M. Andrieu
Prostate-specific antigen doubling time before onset of chemotherapy as a predictor of survival for hormone-refractory prostate cancer patients
Ann. Onc., November 1, 2007; 18(11): 1828 - 1833.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
L. Mueller, F. A. Goumas, M. Affeldt, S. Sandtner, U. M. Gehling, S. Brilloff, J. Walter, N. Karnatz, K. Lamszus, X. Rogiers, et al.
Stromal Fibroblasts in Colorectal Liver Metastases Originate From Resident Fibroblasts and Generate an Inflammatory Microenvironment
Am. J. Pathol., November 1, 2007; 171(5): 1608 - 1618.
[Abstract] [Full Text] [PDF]


Home page
J Ultrasound MedHome page
A. Lyshchik, S. B. Hobbs, A. C. Fleischer, D. Khabele, D.-S. Son, J. C. Gore, and R. R. Price
Ovarian Volume Measurements in Mice With High-Resolution Ultrasonography
J. Ultrasound Med., October 1, 2007; 26(10): 1419 - 1425.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. Lapointe, C. Li, C. P. Giacomini, K. Salari, S. Huang, P. Wang, M. Ferrari, T. Hernandez-Boussard, J. D. Brooks, and J. R. Pollack
Genomic Profiling Reveals Alternative Genetic Pathways of Prostate Tumorigenesis
Cancer Res., September 15, 2007; 67(18): 8504 - 8510.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
L. Zhang, J. Huang, N. Yang, J. Greshock, S. Liang, K. Hasegawa, A. Giannakakis, N. Poulos, A. O'Brien-Jenkins, D. Katsaros, et al.
Integrative Genomic Analysis of Phosphatidylinositol 3'-Kinase Family Identifies PIK3R3 as a Potential Therapeutic Target in Epithelial Ovarian Cancer
Clin. Cancer Res., September 15, 2007; 13(18): 5314 - 5321.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
V. Steger, T. Walles, T. Walker, and G. Friedel
Long-term follow-up of thoracoscopic talc pleurodesis for primary spontaneous pneumothorax
Eur. Respir. J., September 1, 2007; 30(3): 598 - 599.
[Full Text] [PDF]


Home page
J Natl Compr Canc NetwHome page
L. Klotz
Point: Active Surveillance for Favorable Risk Prostate Cancer
J Natl Compr Canc Netw, August 1, 2007; 5(7): 693 - 698.
[Abstract] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
T. Rago, F. Santini, M. Scutari, A. Pinchera, and P. Vitti
Elastography: New Developments in Ultrasound for Predicting Malignancy in Thyroid Nodules
J. Clin. Endocrinol. Metab., August 1, 2007; 92(8): 2917 - 2922.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
J. D. Mosley, J. T. Poirier, D. D. Seachrist, M. D. Landis, and R. A. Keri
Rapamycin inhibits multiple stages of c-Neu/ErbB2 induced tumor progression in a transgenic mouse model of HER2-positive breast cancer
Mol. Cancer Ther., August 1, 2007; 6(8): 2188 - 2197.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
C. A Kuehle, J. Langhorst, S. C Ladd, T. Zoepf, M. Nuefer, F. Grabellus, J. Barkhausen, G. Gerken, and T. C Lauenstein
Magnetic resonance colonography without bowel cleansing: a prospective cross sectional study in a screening population
Gut, August 1, 2007; 56(8): 1079 - 1085.
[Abstract] [Full Text] [PDF]


Home page
Arch DermatolHome page
Erythematous Papules and Plaques Involving the Groin and Scrotum Diagnosis
Arch Dermatol, August 1, 2007; 143(8): 1067 - 1072.
[Full Text] [PDF]


Home page
JCOHome page
Z. Zhao, Y. Xiao, P. Elson, H. Tan, S. J. Plummer, M. Berk, P. P. Aung, I. C. Lavery, J. P. Achkar, L. Li, et al.
Plasma Lysophosphatidylcholine Levels: Potential Biomarkers for Colorectal Cancer
J. Clin. Oncol., July 1, 2007; 25(19): 2696 - 2701.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. ProteomicsHome page
M. Caron, G. Choquet-Kastylevsky, and R. Joubert-Caron
Cancer Immunomics Using Autoantibody Signatures for Biomarker Discovery
Mol. Cell. Proteomics, July 1, 2007; 6(7): 1115 - 1122.
[Abstract] [Full Text] [PDF]


Home page
QJMHome page
D.A. Lane, G.Y.H. Lip, and D.G. Beevers
Ethnic differences in cancer incidence and mortality: the Birmingham Factory Screening Project
QJM, July 1, 2007; 100(7): 423 - 431.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
V. Lamy, S. Roussi, M. Chaabi, F. Gosse, N. Schall, A. Lobstein, and F. Raul
Chemopreventive effects of lupulone, a hop {beta}-acid, on human colon cancer-derived metastatic SW620 cells and in a rat model of colon carcinogenesis
Carcinogenesis, July 1, 2007; 28(7): 1575 - 1581.
[Abstract] [Full Text] [PDF]


Home page
Mayo Clin Proc.Home page
D. Kademani
Oral Cancer
Mayo Clin. Proc., July 1, 2007; 82(7): 878 - 887.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Radiol.Home page
P Veit-Haibach, G Antoch, T Beyer, H Stergar, R Schleucher, E A M Hauth, and A Bockisch
FDG-PET/CT in restaging of patients with recurrent breast cancer: possible impact on staging and therapy
Br. J. Radiol., July 1, 2007; 80(955): 508 - 515.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
L. Zhu, G. Shi, C. Max. Schmidt, R. H. Hruban, and S. F. Konieczny
Acinar Cells Contribute to the Molecular Heterogeneity of Pancreatic Intraepithelial Neoplasia
Am. J. Pathol., July 1, 2007; 171(1): 263 - 273.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
T. Kiziltepe, T. Hideshima, L. Catley, N. Raje, H. Yasui, N. Shiraishi, Y. Okawa, H. Ikeda, S. Vallet, S. Pozzi, et al.
5-Azacytidine, a DNA methyltransferase inhibitor, induces ATR-mediated DNA double-strand break responses, apoptosis, and synergistic cytotoxicity with doxorubicin and bortezomib against multiple myeloma cells
Mol. Cancer Ther., June 1, 2007; 6(6): 1718 - 1727.
[Abstract] [Full Text] [PDF]


Home page
Ann OncolHome page
J-C Eymard, F Priou, A Zannetti, A Ravaud, D Lepille, P Kerbrat, P Gomez, B Paule, D Genet, P Herait, et al.
Randomized phase II study of docetaxel plus estramustine and single-agent docetaxel in patients with metastatic hormone-refractory prostate cancer
Ann. Onc., June 1, 2007; 18(6): 1064 - 1070.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
P. Tooker, W.-C. Yen, S.-C. Ng, A. Negro-Vilar, and T. W. Hermann
Bexarotene (LGD1069, Targretin), a Selective Retinoid X Receptor Agonist, Prevents and Reverses Gemcitabine Resistance in NSCLC Cells by Modulating Gene Amplification
Cancer Res., May 1, 2007; 67(9): 4425 - 4433.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
A. L. Welm, J. B. Sneddon, C. Taylor, D. S. A. Nuyten, M. J. van de Vijver, B. H. Hasegawa, and J. M. Bishop
The macrophage-stimulating protein pathway promotes metastasis in a mouse model for breast cancer and predicts poor prognosis in humans
PNAS, May 1, 2007; 104(18): 7570 - 7575.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
B. J. Giantonio, P. J. Catalano, N. J. Meropol, P. J. O'Dwyer, E. P. Mitchell, S. R. Alberts, M. A. Schwartz, and A. B. Benson III
Bevacizumab in Combination With Oxaliplatin, Fluorouracil, and Leucovorin (FOLFOX4) for Previously Treated Metastatic Colorectal Cancer: Results From the Eastern Cooperative Oncology Group Study E3200
J. Clin. Oncol., April 20, 2007; 25(12): 1539 - 1544.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
U. Gatzemeier, A. Pluzanska, A. Szczesna, E. Kaukel, J. Roubec, F. De Rosa, J. Milanowski, H. Karnicka-Mlodkowski, M. Pesek, P. Serwatowski, et al.
Phase III Study of Erlotinib in Combination With Cisplatin and Gemcitabine in Advanced Non-Small-Cell Lung Cancer: The Tarceva Lung Cancer Investigation Trial
J. Clin. Oncol., April 20, 2007; 25(12): 1545 - 1552.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
C. Pepe, B. Hasan, T. L. Winton, L. Seymour, B. Graham, R. B. Livingston, D. H. Johnson, J. R. Rigas, K. Ding, and F. A. Shepherd
Adjuvant Vinorelbine and Cisplatin in Elderly Patients: National Cancer Institute of Canada and Intergroup Study JBR.10
J. Clin. Oncol., April 20, 2007; 25(12): 1553 - 1561.
[Abstract] [Full Text] [PDF]


Home page
Ann OncolHome page
A Psyrri, P Kountourakis, Z Yu, C Papadimitriou, S Markakis, R. Camp, T Economopoulos, and M. Dimopoulos
Analysis of p53 protein expression levels on ovarian cancer tissue microarray using automated quantitative analysis elucidates prognostic patient subsets
Ann. Onc., April 1, 2007; 18(4): 709 - 715.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
M. G. del Carmen, E. F. Halpern, D. B. Kopans, B. Moy, R. H. Moore, P. E. Goss, and K. S. Hughes
Mammographic Breast Density and Race
Am. J. Roentgenol., April 1, 2007; 188(4): 1147 - 1150.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. C. Shor, E. A. Keschman, F. Y. Lee, C. Muro-Cacho, G. D. Letson, J. C. Trent, W. J. Pledger, and R. Jove
Dasatinib Inhibits Migration and Invasion in Diverse Human Sarcoma Cell Lines and Induces Apoptosis in Bone Sarcoma Cells Dependent on Src Kinase for Survival
Cancer Res., March 15, 2007; 67(6): 2800 - 2808.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. Menon, D. R. Soto-Pantoja, M. F. Callahan, J. M. Cline, C. M. Ferrario, E. A. Tallant, and P. E. Gallagher
Angiotensin-(1-7) Inhibits Growth of Human Lung Adenocarcinoma Xenografts in Nude Mice through a Reduction in Cyclooxygenase-2
Cancer Res., March 15, 2007; 67(6): 2809 - 2815.
[Abstract] [Full Text] [PDF]

eLetters:

Read all eLetters

Cancer Statistics 2004
M. Steven Piver
CA Online, 7 Jun 2004 [Full text]
Re: US Ovarian Cancer Cases and Deaths 2004
Ahmedin Jemal
CA Online, 5 Aug 2004 [Full text]



HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVECOVER ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by American Cancer Society.